ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.99716del (p.Asn33239fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV003226063 SCV003922160 uncertain significance Myopathy, myofibrillar, 9, with early respiratory failure 2023-05-02 criteria provided, single submitter curation The heterozygous p.Asn33239ThrfsTer18 variant in TTN was identified by our study in one individual with myofibrillar myopathy. The p.Asn33239ThrfsTer18 variant in TTN has not been previously reported in individuals with myofibrillar myopathy-9 with early respiratory failure. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 33239 and leads to a premature termination codon 18 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. It is of note that heterozygous loss of function of TTN in autosomal dominant myofibrillar myopathy-9 with early respiratory failure has not yet been established based on the criteria laid out in Tayoun et al., 2018 (PMID: 30192042). In summary, the clinical significance of the p.Asn33239ThrfsTer18 variant in TTN is uncertain. ACMG/AMP Criteria applied: PM2_Supporting (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.